Clinical Trial Update: Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating hyperpolarized 13C-pyruvate metabolic MRI for traumatic brain injury and subarachnoid hemorrhage; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage
• Traumatic Brain Injury

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Traumatic Brain Injury, Subarachnoid Hemorrhage | Phase 1 | Status: RECRUITING